Relative Benefit of Dual vs Single Antiplatelet Therapy Among Patients With Atrial Fibrillation on Oral Anticoagulation According to Time After ACS and PCI
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Circulation: Cardiovascular Interventions
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Relative Benefit of Dual Versus Single Antiplatelet Therapy Among Patients With Atrial Fibrillation on Oral Anticoagulation According to Time After ACS and PCI: Insights From the AUGUSTUS Trial
Circ Cardiovasc Interv 2024 Nov 06;[EPub Ahead of Print], AC Fanaroff, DM Wojdyla, CB Granger, SG Goodman, RS Aronson, S Windecker, R Mehran, JH Alexander, RD LopesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.